World Pharma News

18

Jun2018
Teva is discontinuing a late-stage trial assessing the efficacy of its experimental anti-CGRP therapy fremanezumab in reducing cluster ... Read More

18

Jun2018
A new study authored by scientists from the American Cancer Society, the Harvard T.H. Chan School of Public ... Read More

18

Jun2018
Blocking a unique type of cell death that occurs in multiple sclerosis could be a way to halt ... Read More

18

Jun2018
OTTAWA, June 14, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medicines, today announced the ... Read More